Walleye Trading’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,809
Closed -$76K 6031
2021
Q2
$76K Sell
21,809
-55,975
-72% -$192K ﹤0.01% 4484
2021
Q1
$266K Buy
+77,784
New +$1.47M ﹤0.01% 3370
2020
Q4
Sell
-18,423
Closed -$247K 5088
2020
Q3
$247K Buy
+18,423
New +$522K ﹤0.01% 2841

Other funds holding ODT

Walleye Trading's ODT Position: Q3 2021 in Review

Walleye Trading sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2021, closing a stake of 21,809 shares — an estimated $76K sold.

Walleye Trading first reported a position in ODT in Q3 2020 and held it in 3 quarters. The position peaked at $266K in Q1 2021. 58 funds tracked by Wall St. Rank hold ODT as of Q3 2021.

  • Walleye Trading reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 21,809 Odonate Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $76K.
  • Walleye Trading first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Walleye Trading's Odonate Therapeutics, Inc. Common Stock position peaked at $266K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.